WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Pregabalin is an anticonvulsive
agent prescribed as a secondary analgesic for patients when standard pain treatment is …

Aliment Pharmacol Ther 2011; 34: 878–887 Summary Background Pregabalin has a broad
spectrum of analgesic and antihyperalgesic activity in both basic and clinical studies …

Background Pregabalin is approved by the US Food and Drug Administration for the
treatment of fibromyalgia (FM), diabetic peripheral neuropathy (DPN), postherpetic neuralgia …

Background Patients with chronic pain conditions such as neuropathic pain frequently
experience delays in diagnosis and treatment. Ideally, all patients should be treated in a …

Background Pain control in chronic pancreatitis is a major challenge; the mechanisms
behind analgesic treatment are poorly understood. This study aims to investigate the …

Objective. Neuropathic pain associated with postherpetic neuralgia (PHN) and painful
diabetic peripheral neuropathy (DPN) can be intractable and may not respond to commonly …

Pregabalin is an alpha-2-delta ligand proven effective for the treatment of neuropathic pain
associated with diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN) …

Background: Pregabalin is frequently prescribed for chronic non-cancer pain. No previous
study has examined its off-label use. Objectives: Our primary aim was to assess the …

Aims: Conventional approaches to the management of neuropathic pain (NeP) often yield
unsatisfactory results. We aimed to investigate pregabalin, a gamma‐aminobutyric acid …

Background Pregabalin is an α2δ ligand indicated in the USA for treatment of a number of
chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia …